|
[1]
|
Martinez R, Lloyd-Sherlock P, Soliz P, Ebrahim S, Vega E, Ordunez P, et al. Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990-2017: a population-based study. Lancet Glob Health 2020;8(4):e511 − 23. http://dx.doi.org/10.1016/s2214-109x(20)30035-8CrossRef
|
|
[2]
|
Li YZ, Teng D, Shi XG, Qin GJ, Qin YF, Quan HB, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ 2020;369:m997. http://dx.doi.org/10.1136/bmj.m997CrossRef
|
|
[3]
|
Zheng XY, Luo YN, Su BB, He P, Guo C, Tian YH, et al. Developmental gerontology and active population aging in China. China CDC Wkly 2023;5(8):184 − 7. http://dx.doi.org/10.46234/ccdcw2023.033CrossRef
|
|
[4]
|
Zheng XY, Guo C. Strengthening systematic research on aging: reflections from an omics perspective. China CDC Wkly 2022;4(39):875 − 8. http://dx.doi.org/10.46234/ccdcw2022.181CrossRef
|
|
[5]
|
Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. World Health Organization. 2001;9(10):1 − 14. https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard.https://www.researchgate.net/publication/284696312_Age_Standardization_of_Rates_A_New_WHO_Standard |
|
[6]
|
Zou ZY, Cini K, Dong B, Ma YH, Ma J, Burgner DP, et al. Time trends in cardiovascular disease mortality across the BRICS: an age-period-cohort analysis of key nations with emerging economies using the global burden of disease study 2017. Circulation 2020;141(10):790 − 9. http://dx.doi.org/10.1161/circulationaha.119.042864CrossRef
|
|
[7]
|
The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010;375(9733):2215 − 22. http://dx.doi.org/10.1016/s0140-6736(10)60484-9CrossRef
|
|
[8]
|
Wang LM, Peng W, Zhao ZP, Zhang M, Shi ZM, Song ZW, et al. Prevalence and treatment of diabetes in China, 2013-2018. JAMA 2021;326(24):2498 − 506. http://dx.doi.org/10.1001/jama.2021.22208CrossRef
|
|
[9]
|
Li YY, Kou CG, Bai W, Hua WQ, Yu WY, Song Y, et al. Trends in diabetes mortality by gender in urban and rural areas in China from 2003 to 2012: an age-period-cohort analysis. Asia Pac J Public Health 2019;31(3):238 − 45. http://dx.doi.org/10.1177/1010539519841288CrossRef
|
|
[10]
|
Muka T, Nano J, Jaspers L, Meun C, Bramer WM, Hofman A, et al. Associations of steroid sex hormones and sex hormone-binding globulin with the risk of type 2 diabetes in women: a population-based cohort study and meta-analysis. Diabetes 2017;66(3):577 − 86. http://dx.doi.org/10.2337/db16-0473CrossRef
|
|
[11]
|
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2019;157:107843. http://dx.doi.org/10.1016/j.diabres.2019.107843CrossRef
|